Kong JY - Search Results

1

Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment.

Byeon SR, Kim HV, Jeon M, Ahn YG, Kim MS, Kong JY, Kim HY, Kim YS, Kim DJ. Byeon SR, et al. Among authors: kong jy. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3467-9. doi: 10.1016/j.bmcl.2013.02.104. Epub 2013 Mar 13. Bioorg Med Chem Lett. 2013. PMID: 23601707

2

Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice.

Lee SH, Kim Y, Kim HY, Kim YH, Kim MS, Kong JY, Lee MH, Kim DJ, Ahn YG. Lee SH, et al. Among authors: kong jy. PLoS One. 2014 Apr 23;9(4):e95733. doi: 10.1371/journal.pone.0095733. eCollection 2014. PLoS One. 2014. PMID: 24760018 Free PMC article.

3

Synthesis and biological evaluation of novel 1 beta-methylcarbapenems with isothiazoloethenyl side chains.

Kang YK, Lee KS, Yoo KH, Shin KJ, Kim DC, Lee CS, Kong JY, Kim DJ. Kang YK, et al. Among authors: kong jy. Bioorg Med Chem Lett. 2003 Feb 10;13(3):463-6. doi: 10.1016/s0960-894x(02)00948-4. Bioorg Med Chem Lett. 2003. PMID: 12565951

4

Synthesis and biological activity of novel 1beta-methylcarbapenems with oxyiminopyrrolidinylamide moiety.

Lee JH, Lee KS, Kang YK, Yoo KH, Shin KJ, Kim DC, Kong JY, Lee Y, Lee SJ, Kim DJ. Lee JH, et al. Among authors: kong jy. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4399-403. doi: 10.1016/j.bmcl.2003.09.039. Bioorg Med Chem Lett. 2003. PMID: 14643334

5

Studies on novel 3-isoxazolylvinyl-cephalosporins: II. Synthesis and biological activity of 7-[2-(2-aminothiazol-4-yl)-2-hydroxy-iminoacetamido] derivatives.

Choi KI, Cha JH, Pae AN, Cho YS, Kim Y, Chang MH, Park SH, Park SY, Kim D, Jeong DY, Kim YH, Kong JY, Koh HY. Choi KI, et al. Among authors: kong jy. J Antibiot (Tokyo). 1998 Dec;51(12):1122-5. doi: 10.7164/antibiotics.51.1122. J Antibiot (Tokyo). 1998. PMID: 10048574 Free article. No abstract available.

6

Classification of dopamine antagonists using functional feature hypothesis and topological descriptors.

Kim HJ, Cho YS, Koh HY, Kong JY, No KT, Pae AN. Kim HJ, et al. Among authors: kong jy. Bioorg Med Chem. 2006 Mar 1;14(5):1454-61. doi: 10.1016/j.bmc.2005.09.072. Epub 2005 Oct 25. Bioorg Med Chem. 2006. PMID: 16256354

7

Preparation of piperazine derivatives as 5-HT7 receptor antagonists.

Yoon J, Yoo EA, Kim JY, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY. Yoon J, et al. Among authors: kong jy. Bioorg Med Chem. 2008 May 15;16(10):5405-12. doi: 10.1016/j.bmc.2008.04.023. Epub 2008 Apr 15. Bioorg Med Chem. 2008. PMID: 18456500

8

Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.

Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY. Choi KI, et al. Among authors: kong jy. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2795-800. doi: 10.1016/s0960-894x(99)00477-1. Bioorg Med Chem Lett. 1999. PMID: 10522693

9

Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.

Lee KI, Park Y, Park SJ, Hwang JH, Lee SJ, Kim GD, Park WK, Lee S, Jeong D, Kong JY, Kang HK, Cho H. Lee KI, et al. Among authors: kong jy. Bioorg Med Chem Lett. 2006 Feb;16(3):737-42. doi: 10.1016/j.bmcl.2005.08.115. Bioorg Med Chem Lett. 2006. PMID: 16321529

10

Flavonoids as receptor tyrosine kinase FLT3 inhibitors.

Chin YW, Kong JY, Han SY. Chin YW, et al. Among authors: kong jy. Bioorg Med Chem Lett. 2013 Mar 15;23(6):1768-70. doi: 10.1016/j.bmcl.2013.01.049. Epub 2013 Jan 26. Bioorg Med Chem Lett. 2013. PMID: 23411073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters